Wire · regulatory
BIS Settlement Highlights Export Control Risks for Medical and Research Technology
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 August 2026 · Fusion42 review
The U.S. BIS settled with Plexon, Inc. for $1.7 million over unlicensed exports of neural recording systems to a Chinese military-linked research institution on the Entity List, highlighting that medical and research technologies remain subject to export controls including for EAR99 classified items.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 15 Aug 2026 and 20 Aug 2026.
◆ ◆ The Wire takeaway
You must treat medical and research technology exports like regulated military tech, enforcing export license checks on every transaction. Your compliance can no longer rely on product labels or old customer lists—ongoing screening is now critical.
◆ Coverage
2 sources · first reported 15 Aug 2026 · latest 20 Aug 2026
◆ Related on Wire
◆ Topics